Implications of prescribing a fixed-dose combination in clinical cardiology practice: a retrospective observational study using a single medical centre database in Korea

Heart Asia
Hyungseop KimKwon-Bae Kim

Abstract

Fixed-dose combination (FDC) prescribing enhances adherence to medication. However, there are limited data regarding the usefulness of FDC drugs across different risk groups. The aim of this study was to explore the relationship between FDC discontinuation and clinical outcomes. From January 2008 to December 2014, patients with FDC prescriptions who visited a cardiology outpatient clinic at a tertiary university hospital in Daegu, Republic of Korea were retrospectively identified. The 10-year atherosclerotic cardiovascular disease (ASCVD) risk score and 20 conventional cardiovascular (CV) risk factors were assessed. Patients were classified according to FDC continuation, together with a tertile of 20 risks. CV events were defined as the composite of admission for worsening heart failure or diabetes, stroke, ischaemic heart disease, and CV death. 502 patients were prescribed with one of the following FDC products: calcium channel blocker (CCB) plus angiotensin receptor blockers (ARB), CCB plus statins, and ARB plus diuretics. During follow-up (mean 2.8±2.4 years), 203 discontinuations (40.4%) occurred. FDC-discontinued patients had lower ASCVD risk scores (24.8% vs. 28.8%, p<0.001), and patients with <6 risk factors discontinued...Continue Reading

References

Apr 20, 2002·Lancet·Taane G ClarkBianca L De Stavola
Feb 23, 2010·Journal of General Internal Medicine·Alan J ChristensenGary E Rosenthal
Dec 1, 2007·International Journal of Older People Nursing·Krystyna Cholowski, Robert Cantwell
Sep 3, 2011·American Heart Journal·Hayden B BosworthChristopher B Granger
Jun 23, 2012·Heart Failure Reviews·R Oosterom-CaloJ Brug
Aug 8, 2012·High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension·Fabio AngeliPaolo Verdecchia
Feb 16, 2013·Current Medicinal Chemistry·A I Wertheimer
Apr 30, 2013·Progress in Cardiovascular Diseases·Ian M Kronish, Siqin Ye
Sep 5, 2013·JAMA : the Journal of the American Medical Association·Simon ThomUNKNOWN UMPIRE Collaborative Group
Feb 5, 2014·Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association·Derek R Anderson, Charles F Emery
Mar 29, 2014·European Journal of Preventive Cardiology·Anushka PatelUNKNOWN Kanyini Guidelines Adherence with the Polypill (Kanyini GAP) Collaboration
Jun 25, 2014·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Heli HalavaJussi Vahtera
Sep 7, 2014·Journal of the American College of Cardiology·José M CastellanoValentin Fuster
Nov 13, 2015·Expert Opinion on Drug Delivery·Ruth Webster, Anthony Rodgers
Jan 9, 2016·European Journal of Preventive Cardiology·Melvin LafeberUNKNOWN Programme to Improve Life and Longevity (PILL) Collaborative Group

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Cardiovascular Disorder in Diabetes

Diabetes is associated with an increased risk of cardiovascular disorders and heart failure. Discover the latest research here.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.